Saturday - November 15, 2025
Vigil Neuroscience To Be Acquired by Sanofi For 470 Million and Contingent Value Rights
May 22, 2025
BOSTON, Massachusetts, May 22 [Category: BizLaw/Legal] -- Goodwin, a law firm, issued the following news release:

* * *

Vigil Neuroscience To Be Acquired by Sanofi For 470 Million and Contingent Value Rights

The Life Sciences and Public M&A teams advised Vigil Neuroscience (Nasdaq: VIGL) in its definitive agreement to be acquired by Sanofi (NASDAQ: SNY) for an upfront payment of $8.00 per share of common stock in cash. Vigil shareholders will also recei . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products